Chemical Structure (Zusduri 01)
Zusduri Kit
Product Images NDC 72493-106
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 43 technical images submitted to the FDA as part of the official labeling for Zusduri (NDC 72493-106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Urogen Pharma, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Zusduri 02)
Image (Zusduri 03)
Image (Zusduri 04)
Image (Zusduri 05)
Image (Zusduri 06)
Image (Zusduri 07)
Image (Zusduri 08)
Image (Zusduri 09)
Image (Zusduri 10)
Image (Zusduri 11)
Figure 1 (Zusduri 12)
Image (Zusduri 13)
Figure 1 (Zusduri 14)
Image (Zusduri 15)
Figure 1 (Zusduri 16)
Image (Zusduri 17)
Image (Zusduri 18)
Image (Zusduri 19)
Image (Zusduri 20)
Image (Zusduri 21)
Image (Zusduri 22)
Image (Zusduri 23)
Image (Zusduri 24)
Image (Zusduri 25)
Image (Zusduri 26)
Image (Zusduri 27)
Image (Zusduri 28)
Image (Zusduri 29)
Image (Zusduri 30)
Image (Zusduri 31)
Image (Zusduri 32)
Image (Zusduri 33)
Image (Zusduri 34)
Image (Zusduri 35)
Image (Zusduri 36)
Image (Zusduri 37)
Image (Zusduri 38)
Image (Zusduri 39)
Principal Display Panel (40 mg Kit Carton)
This is a single-dose kit for intravesical use containing 2 vials of ZUSDURI (mitomycin) solution with 40 mg per vial, 1 single-dose vial of sterile hydrogel (60 mL), and 1 admixture label. Prior to dispensing, reconstitution is necessary. The product is intended for pharmacy use, with full prescribing information available. It is important to note that this medication is specifically for intravesical use only, and the contents should be used according to the instructions provided.*
Principal Display Panel (40 mg Vial Label)
This is a description of a medication with the NDC number 72493-104-40 presented as a Single-Dose Vial. It contains 40 mg of Mitomycin for intravesical solution. The instructions recommend reconstitution with sterile hydrogel before use. It is essential for intravesical use only, with storage instructions between 20°C to 25°C. The vial also includes mannitol and should be protected from excessive heat and light. The recommended dosage can be found in the full prescribing information. This medication is distributed by UroGen Pharma, Inc. and is a hazardous drug for prescription use only.*
Principal Display Panel (60 mL Vial Label)
This is a product label for a sterile hydrogel solution containing methycellulose, poloxamer, polyethylene glycol, and mitomycin. It is intended for intravesical administration as a solution in water for injection. The solution is stored at 20°C to 25°C and each vial contains 60 mL. The product is distributed by UroGen Pharma, Inc., and it provides instructions for pharmacy preparation.*
Image (Zusduri 43)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
